For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
The core portfolio consists of over 240 recombinant rabbit monoclonal antibodies, branded Spring Proprietary Clones (SP Clones). These are widely recognized as best-in-class IHC markers and are made using the same proprietary technology as our existing RabMAb® antibodies with the same high levels of specificity and sensitivity.
In addition to the SP Clones, the agreement covers additional antibody products (mouse monoclonal and polyclonals) along with IHC detection and ancillary products.
This agreement represents an exciting step in the ongoing collaborative and long-term relationship between our two businesses. Adding these Spring antibodies to our portfolio provides our customers with access to more products for their most important targets. With recombinant antibodies like those from Spring, we can help to ensure researchers can generate accurate and reproducible results, and ultimately help to speed up the progress of scientific discovery. This collaboration complements our effort to minimize the time, effort, and money wasted in research.
These products will be available to buy exclusively from us from February 21, 2018.